Two Federal Cannabis Proposals, One Week Apart: What Actually Affects Your Business

Two developments hit federal cannabis policy within days of each other. On July 16, 2026, Senate Democratic Leader Chuck Schumer, along with Sens. Cory Booker and Ron Wyden, reintroduced the Cannabis Administration and Opportunity Act (CAOA), legislation that would strip cannabis out of the federal Controlled Substances Act completely. Seventeen senators signed on. The timing was not subtle: it landed one day after the DEA closed out a hearing on a smaller idea, reclassifying marijuana to Schedule III instead of removing it from federal drug law entirely.

Reclassification is the one already moving through a federal agency, so it is tempting to treat it as the bigger deal, and it would help. Section 280E of the tax code bars cannabis businesses from deducting ordinary expenses like rent and payroll, because it applies specifically to Schedule I and II substances. Businesses can still subtract the cost of goods sold to reach gross income, but nothing beyond that under current law. Moving cannabis to Schedule III would take it out of Section 280E’s reach entirely. But rescheduling would not legalize cannabis the way most operators picture it. Schedule III is a medical, prescription-based framework, not general legalization of adult-use retail. Existing state-licensed businesses would not automatically qualify either; the DEA would need to register each one individually, a discretionary process. Cannabis would also remain restricted from crossing state lines, and the Supreme Court has already confirmed Congress can regulate cannabis even where a state has legalized it.

The CAOA aims at that larger gap. It would deschedule cannabis outright, move oversight to the Alcohol and Tobacco Tax and Trade Bureau, tax producers on a sliding scale starting at 5% for smaller operations, and automatically clear non-violent federal cannabis convictions. It would also remove the main federal barrier keeping traditional banks out of the industry, something reclassification alone does not touch, though actual bank participation would still depend on separate federal banking rules. A related bill, the SAFER Banking Act, has been introduced repeatedly to address banking specifically.

None of this changes what is required under Montana law in the meantime. The Montana Marijuana Regulation and Taxation Act governs the state’s licensed market on its own terms, requiring in-state cultivation, seed-to-sale tracking, lab testing, and a separate ban on synthetic cannabinoids. Local governments can still block a cannabis business even with state licensure. Montana law does have one built-in link to federal scheduling: if the FDA ever authorizes prescription THC, Montana’s own schedule automatically updates to match. Short of that, state-level legalization does not shield an operator from federal law.

This is the CAOA’s third trip through the Senate since 2021, and the first two versions both drew attention before stalling in committee without a vote. The specific ideas in it, the tax brackets, the TTB shift, the expungement framework, tend to resurface in smaller bills later even when a broad one like this does not pass. Worth remembering regardless of where this particular bill ends up.

If you are trying to figure out what any of this means for your license, your taxes, or your standing under Montana law, that is the conversation to have now. Ironleaf can walk you through it.